Base on the results, treatment with RTA404 induces the loss of glioma cell mitochondrial membrane potential that is involved in intrinsic pathways and activates caspase 3 to initiate the execution phase of apoptosis, which leads to cell death. This evidence concerns the gene CASP3 and central nervous system cancer.